14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:XLRN
Delisted

Acceleron Pharma Inc. Stock Price (Quote)

$178.75
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $178.75 $178.75 Friday, 27th May 2022 XLRN stock ended at $178.75. During the day the stock fluctuated 0% from a day low at $178.75 to a day high of $178.75.
90 days $178.75 $178.75
52 weeks $113.49 $189.99

Historical Acceleron Pharma Inc. prices

Date Open High Low Close Volume
Dec 06, 2018 $48.01 $50.22 $47.69 $49.96 472 234
Dec 04, 2018 $53.54 $54.90 $48.85 $48.94 575 521
Dec 03, 2018 $55.82 $56.91 $51.74 $53.85 675 329
Nov 30, 2018 $53.00 $54.14 $52.33 $52.93 316 719
Nov 29, 2018 $53.10 $54.02 $51.90 $52.96 242 781
Nov 28, 2018 $52.14 $53.51 $50.77 $53.50 515 786
Nov 27, 2018 $51.74 $52.35 $50.70 $51.53 232 516
Nov 26, 2018 $51.34 $52.38 $50.39 $52.19 305 682
Nov 23, 2018 $50.17 $52.55 $50.17 $50.66 121 219
Nov 21, 2018 $50.25 $50.94 $49.18 $50.43 192 266
Nov 20, 2018 $50.61 $51.37 $47.79 $49.80 386 524
Nov 19, 2018 $52.13 $52.89 $50.34 $51.42 453 588
Nov 16, 2018 $50.14 $52.57 $49.80 $52.23 596 509
Nov 15, 2018 $49.62 $50.72 $49.24 $50.66 303 777
Nov 14, 2018 $51.34 $51.80 $49.24 $50.00 316 891
Nov 13, 2018 $52.13 $53.18 $50.58 $51.36 255 736
Nov 12, 2018 $54.64 $55.13 $51.40 $51.64 326 172
Nov 09, 2018 $58.11 $58.11 $53.63 $54.89 310 168
Nov 08, 2018 $55.99 $59.08 $55.56 $57.72 753 040
Nov 07, 2018 $54.58 $56.36 $53.20 $56.13 362 600
Nov 06, 2018 $53.62 $55.75 $52.84 $53.50 314 369
Nov 05, 2018 $53.50 $54.37 $52.10 $53.95 173 462
Nov 02, 2018 $51.80 $53.72 $50.52 $53.20 301 750
Nov 01, 2018 $51.25 $52.53 $48.60 $51.64 758 858
Oct 31, 2018 $49.95 $51.46 $47.62 $50.77 828 877
Click to get the best stock tips daily for free!

About Acceleron Pharma Inc.

Acceleron Pharma. Acceleron Pharma Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of protein therapeutics for cancer and rare diseases. It is developing sotatercept to treat patients with chronic kidney disease, including mineral-bone disorder, vascular calcification, and anemia; and luspatercept to treat anemia and associated complications in patients with myelodysplastic syndromes and beta-thalassem... XLRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT